DNLI vs UHS · rev $3.6M vs P/E 5.9, rev $9.13B
Denali Therapeutics Inc (DNLI) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
DNLI currently screens at market cap $2.11B. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the DNLI and UHS stock pages for the full models.
Not investment advice.